Impact of somatization on health resource usage in patients with irritable bowel syndromeSeptember 28, 2005Patients with irritable bowel syndrome (IBS) use over 50 percent more health resources than people without the disorder. Even though there are definitive guidelines to diagnose IBS through simple blood tests, many IBS patients have additional procedures and surgeries that rarely result in relief or any additional diagnostic findings. "It is difficult to know why patients with IBS have such a high use of healthcare resources, and whether the high use is driven by the patients themselves or by the physicians taking care of them," said Dr. Brennan M.R. Spiegel, study author and director, UCLA/VA Center for Outcomes Research and Education (CORE). UCLA researchers tried to tease this out by analyzing the effect of somatization on the amount of health care resources utilized by patients with IBS. Somatization is a condition where emotional stressors trigger physical pain without the presence of disease. The new study is published in the October 2005 issue of the American Journal of Gastroenterology. According to Spiegel, IBS patients often suffer from somatization. Since patients with somatization are sometimes perceived as "complainers" by their doctors, the researchers hypothesized that physicians might respond to these complaints by ordering excessive tests instead of treating the somatization itself. Researchers found that patients with high levels of somatization were not more likely to seek gastrointestinal care than those with low levels of the condition. Once evaluated for care by the doctors however, the patients with more severe somatization were significantly more likely to utilize more health care services. "This finding suggests that the doctors and not the patients may be driving the need for procedures and surgeries that may not be necessary," said Dr. Brennan M.R. Spiegel, assistant professor of medicine, David Geffen School of Medicine at UCLA and VA Greater Los Angeles Healthcare System. "We need to educate and train doctors to recognize somatization and treat this condition appropriately, rather than order a number of diagnostic tests as a reaction in the face of symptoms that are otherwise difficult to explain." Spiegel noted that doctors should work closely with patients to diagnose and treat IBS, while also addressing the influence of stress and somatization, which is most often treated through cognitive behavioral training. More severe levels can be helped with anxiety and anti-depression medications. An entirely new field has emerged called neurogastroenterology to scientifically study how the nervous and digestive systems interact in health and disease. One important question is how emotional stressors may alter the way patients with irritable bowel syndrome perceive and respond to gut stimuli. "In many IBS patients the brain interprets and responds to sensations arising from the digestive system differently, causing abdominal discomfort and pain on the one side, and altered bowel habits on the other - generally without evidence of more serious disease, such as colitis or cancer," said Dr. Emeran Mayer, study author and professor of medicine, physiology and psychiatry and director of The Center for Neurovisceral Sciences & Women's Health where the study was performed. "We are just beginning to understand the mind-body connection in these conditions." Researchers analyzed questionnaires completed by 1,410 IBS patients seen at the Integrative Medicine and Women's Digestive Health Clinic at UCLA. The questionnaires included information on health care services utilized, psychological symptoms, and a health survey. Investigators then measured one year of direct gastrointestinal health care costs used by the patients including physician visits, procedures and surgeries, as well as examined the number of visits to a gastrointestinal specialist in a year's time. University of California-Los Angeles |
|||||||||||||||||||||
| Related Irritable Bowel Syndrome Current Events and Irritable Bowel Syndrome News Articles Antidepressant and placebo are equally effective in child pain relief When used "off-label," the antidepressant amitriptyline works just as well as placebo in treating pain-predominant gastrointestinal disorders in children, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. What is alternative treatment for irritable bowel syndrome when conventional therapy has failed? IBS remains a common intestinal disorder causing significant discomfort and poor quality of life in patients who have the diagnosis. Pinpointing cause of colic: UT Houston research identifies organism that could trigger constant crying Researchers at The University of Texas Health Science Center at Houston say one organism discovered during their study may unlock the key to what causes colic, inconsolable crying in an otherwise healthy baby. Mayo Clinic study finds celiac disease 4 times more common than in 1950s Celiac disease, an immune system reaction to gluten in the diet, is over four times more common today than it was 50 years ago, according to findings of a Mayo Clinic study published this month in the journal Gastroenterology. Review of probiotic trial research finds only Bifantis able to claim efficacy for IBS symptoms A review by researchers at Northwestern University (Chicago, IL.) and University of Michigan (Ann Arbor, MI) of the utility of probiotics in the treatment of Irritable Bowel Syndrome (IBS) found that Bifidobacterium infantis 35624 was the only probiotic strain out of 13 different individual strains or preparations reviewed to significantly improve symptoms of IBS, including abdominal pain, bloating and bowel movement difficulty. New studies examine the effectiveness of probiotics in IBS Several studies presented at the American College of Gastroenterology's 73rd Annual Scientific Meeting in Orlando highlight the safety and efficacy of probiotics in improving symptoms and normalizing bowel movement frequency in patients suffering from constipation or diarrhea related to Irritable Bowel Syndrome (IBS). New study shows health benefits of probiotic could extend to the entire body Data from a recent study demonstrate the anti-inflammatory and pathogen protection benefits of Bifidobacterium infantis 35624 a probiotic bacterial strain of human origin. UT School of Public Health researchers discover significant efficacy of travelers' diarrhea vaccine Researchers at The University of Texas School of Public Health have found that patients given a travelers' diarrhea vaccine were significantly less likely to suffer from clinically significant diarrhea than those who received placebo, according to a study published in this week's edition of the Lancet. The patch-based vaccine is part of the Phase 2 study in conjunction with the Iomai Corporation. Common bowel problem linked to chili pepper pain receptor People with irritable bowel syndrome have a higher than usual number of chilli pepper pain receptors, according to a new study published tomorrow (Wednesday 11 June). Drug brings relief for many IBS patients who experience constipation Many patients may soon find relief from the bloating, cramping, abdominal pain and constipation associated with irritable bowel syndrome, or IBS. More Irritable Bowel Syndrome Current Events and Irritable Bowel Syndrome News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||